Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Asthma (Pediatric)
Location: United States, FL
Does your child have asthma?
A 6-month safety and benefit study of inhaled fluticasone
propionate/ salmeterol combination versus inhaled fluticasone propionate in the treatment of 6,200 pediatric subjects 4-11 years old with persistent asthma. There is no placebo in this clinical research study. There will be no blood draws during this clinical research study. All study participants will receive asthma medication at no charge. Health insurance is not needed to participate. Compensation may be provided for time and travel. Patient Inclusion Description: Are 4 to 11 years of age, have had asthma for at least six months, have had asthma bad enough to see a doctor in the last 12 months.
Patient Exclusion Criteria:
- Subject has unstable asthma in the 7 days prior to Visit 1, Subject has a chronic pulmonary disease OTHER than bronchial asthma, Subject has an acute upper or lower respiratory tract infection at Visit 1, Subject required oral corticosteroids for asthma exacerbation WITHIN 4 weeks of Visit 1, Subject had GREATER than 4 episodes of asthma exacerbation requiring oral corticosteroids in the 12 months prior to Visit 1, Subject had GREATER than 2 hospitalizations for asthma exacerbation in the last 12 months prior to visit 1,
Jeffrey Hirschfield, M.D., Principal Investigator
SCORE Physician Alliance
6499 38Th Avenue North, Suite A-2
St. Petersburg, FL 33710
Research Center Information: SCORE Physician Alliance
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these